SRBCF (SRBCF) Stock Price & Analysis
SRBCF (SRBCF) rose 0.00% to USD 0.01 as of June 10, 2026 at 05:32 UTC, according to Nexqual real-time market data.
SRBCF last closed at USD 0.01; the session ranged USD 0.01–0.01 on volume of 50,000 shares. Market capitalization is $1.63M, with a 52-week range of USD 0–0.02 (PNK). Source: Nexqual, June 10, 2026 at 05:32 UTC.
Key Statistics (as of June 10, 2026 at 05:32 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.02 |
| Volume | 50,000 shares |
| Market Cap | $1.63M |
| Exchange | PNK |
Technical Analysis (SRBCF)
Nexqual's technical model rates SRBCF "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 05:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.01) |
| MACD | 0 (negative) |
Analyst Ratings (SRBCF)
Wall Street analysts rate SRBCF "None", per Nexqual as of June 10, 2026 at 05:32 UTC.
| Consensus Rating | None |
|---|
Earnings (SRBCF)
| Next Earnings Date | 2026-04-22 |
|---|
Source: Nexqual, June 10, 2026 at 05:32 UTC.
Financials & Fundamentals (SRBCF)
| Total Revenue | $-16,363 |
|---|---|
| Revenue Growth (YoY) | -62.70% |
| Gross Margin | +0.00% |
| Operating Margin | -25882.07% |
| Profit Margin | +0.00% |
| Current Ratio | 0.34 |
| Total Cash | $33,622 |
| Total Debt | $3.32M |
| Free Cash Flow | $-1.26M |
Source: Nexqual, June 10, 2026 at 05:32 UTC.
Financial Health Score (SRBCF)
Nexqual rates SRBCF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:32 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $34K cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Mixed — No data |
Ownership (SRBCF)
| Insider Ownership | +4.19% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 258.84M |
| Float | 245.12M |
Source: Nexqual, June 10, 2026 at 05:32 UTC.
Leadership (SRBCF)
SRBCF is led by Howard J. Verrico (age 64), Founder, Chairman of the Board, CEO & Secretary, per Nexqual as of June 10, 2026 at 05:32 UTC.
| Founder, Chairman of the Board, CEO & Secretary | Howard J. Verrico (age 64) |
|---|---|
| CFO & Director | Christopher D. Hopton C.G.A. (age 59) |
| Chief Scientific Officer & Director | Géraldine Deliencourt-Godefroy |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KNBIF | Kane Biotech Inc. | USD 0.03 | ▲ 14.68% |
| BTVRF | BLUERUSH INC. | USD 0 | ▲ 0% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| ACHFF | Arch Biopartners Inc. | USD 0.34 | ▼ 3.41% |
| ACWRF | ACCELEWARE LTD | USD 0.06 | ▲ 5.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:32 UTC. This page is informational and not investment advice.